Skip to content

A prospective, randomised study to compare the effectiveness of the 24 hour versus 12 hour double doses regimen of levonorgestrel for emergency post-coital contraception

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN06428555
Enrollment
2071
Registered
2004-04-01
Start date
1998-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception Pregnancy and Childbirth Contraception

Interventions

1. Levonorgestrel two doses of 0.75 mg 12 hours apart 2. Levonorgestrel two doses of 0.75 mg 24 hours apart

Sponsors

World Health Organisation (WHO) (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Requesting emergency contraception within 120 hours of unprotected intercourse 2. Only one act of unprotected intercourse during current cycle 3. Willing to abstain from further acts during current cycle 4. Regular menstrual cycles (24 to 42 days) 5. Having at least one spontaneous cycle before current cycle 6. Available for follow-up in the next six weeks 7. Negative pregnancy test 8. Willing to participate 9. Not breastfeeding 10. No use of hormonal contraceptives or of rhythm or natural family planning method of contraception during current cycle 11. Not unsure about the date of last menstrual period

Exclusion criteria

Exclusion criteria: 1. Post-abortion or post-partum patients whose period had not yet returned 2. Regular use of prescription drugs before admission to the study 3. Intercourse during the treatment cycle greater than 120 hours before admission into the study

Design outcomes

Primary

MeasureTime frame
Pregnancy rate

Secondary

MeasureTime frame
1. Delay in onset of next menses 2. Incidence of side-effects

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026